Initial antimicrobial treatment of foals with sepsis: Do our choices make a difference?

Mathijs J.P. Theelen, William D Wilson, Barbara A Byrne, Judy M. Edman, Philip H Kass, K G Magdesian

Research output: Contribution to journalArticle

Abstract

The study objectives were to provide cumulative antimicrobial susceptibility data at the patient level and to evaluate the effect of initial antimicrobial treatment on survival in foals with sepsis. Foals below 30 days of age with a diagnosis of sepsis, confirmed by isolation of bacteria from normally sterile sites on the day of hospital admission, were included. Susceptibility testing was performed using the broth microdilution procedure. In total, 213 foals and 306 bacterial isolates were included. The likelihood of survival for foals from which all bacteria were susceptible to the initial antimicrobial treatment was 65.4% (n = 106/162; 95% confidence interval (CI) 57.6% to 72.7%) versus 41.7% (n = 10/24; 95% CI 22.1% to 63.4%) if one or more isolates were resistant (relative risk 1.57, 95% CI 0.96 to 3.06). Based on this study, amikacin combined with ampicillin remains an appropriate antimicrobial drug combination for initial treatment of foals with sepsis.

LanguageEnglish (US)
Pages74-76
Number of pages3
JournalVeterinary Journal
Volume243
DOIs
StatePublished - Jan 1 2019

Fingerprint

foals
Sepsis
anti-infective agents
Confidence Intervals
confidence interval
Bacteria
Survival
Amikacin
Drug Combinations
Ampicillin
Therapeutics
amikacin
combination drug therapy
bacteria
anti-infective properties
relative risk
ampicillin
testing

Keywords

  • Amikacin
  • Ampicillin
  • Antimicrobial resistance
  • Equine
  • Neonatal intensive care unit

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Initial antimicrobial treatment of foals with sepsis : Do our choices make a difference? / Theelen, Mathijs J.P.; Wilson, William D; Byrne, Barbara A; Edman, Judy M.; Kass, Philip H; Magdesian, K G.

In: Veterinary Journal, Vol. 243, 01.01.2019, p. 74-76.

Research output: Contribution to journalArticle

@article{f17187921fd748439455033f37e62c81,
title = "Initial antimicrobial treatment of foals with sepsis: Do our choices make a difference?",
abstract = "The study objectives were to provide cumulative antimicrobial susceptibility data at the patient level and to evaluate the effect of initial antimicrobial treatment on survival in foals with sepsis. Foals below 30 days of age with a diagnosis of sepsis, confirmed by isolation of bacteria from normally sterile sites on the day of hospital admission, were included. Susceptibility testing was performed using the broth microdilution procedure. In total, 213 foals and 306 bacterial isolates were included. The likelihood of survival for foals from which all bacteria were susceptible to the initial antimicrobial treatment was 65.4{\%} (n = 106/162; 95{\%} confidence interval (CI) 57.6{\%} to 72.7{\%}) versus 41.7{\%} (n = 10/24; 95{\%} CI 22.1{\%} to 63.4{\%}) if one or more isolates were resistant (relative risk 1.57, 95{\%} CI 0.96 to 3.06). Based on this study, amikacin combined with ampicillin remains an appropriate antimicrobial drug combination for initial treatment of foals with sepsis.",
keywords = "Amikacin, Ampicillin, Antimicrobial resistance, Equine, Neonatal intensive care unit",
author = "Theelen, {Mathijs J.P.} and Wilson, {William D} and Byrne, {Barbara A} and Edman, {Judy M.} and Kass, {Philip H} and Magdesian, {K G}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.tvjl.2018.11.012",
language = "English (US)",
volume = "243",
pages = "74--76",
journal = "Veterinary Journal",
issn = "1090-0233",
publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - Initial antimicrobial treatment of foals with sepsis

T2 - Veterinary Journal

AU - Theelen, Mathijs J.P.

AU - Wilson, William D

AU - Byrne, Barbara A

AU - Edman, Judy M.

AU - Kass, Philip H

AU - Magdesian, K G

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The study objectives were to provide cumulative antimicrobial susceptibility data at the patient level and to evaluate the effect of initial antimicrobial treatment on survival in foals with sepsis. Foals below 30 days of age with a diagnosis of sepsis, confirmed by isolation of bacteria from normally sterile sites on the day of hospital admission, were included. Susceptibility testing was performed using the broth microdilution procedure. In total, 213 foals and 306 bacterial isolates were included. The likelihood of survival for foals from which all bacteria were susceptible to the initial antimicrobial treatment was 65.4% (n = 106/162; 95% confidence interval (CI) 57.6% to 72.7%) versus 41.7% (n = 10/24; 95% CI 22.1% to 63.4%) if one or more isolates were resistant (relative risk 1.57, 95% CI 0.96 to 3.06). Based on this study, amikacin combined with ampicillin remains an appropriate antimicrobial drug combination for initial treatment of foals with sepsis.

AB - The study objectives were to provide cumulative antimicrobial susceptibility data at the patient level and to evaluate the effect of initial antimicrobial treatment on survival in foals with sepsis. Foals below 30 days of age with a diagnosis of sepsis, confirmed by isolation of bacteria from normally sterile sites on the day of hospital admission, were included. Susceptibility testing was performed using the broth microdilution procedure. In total, 213 foals and 306 bacterial isolates were included. The likelihood of survival for foals from which all bacteria were susceptible to the initial antimicrobial treatment was 65.4% (n = 106/162; 95% confidence interval (CI) 57.6% to 72.7%) versus 41.7% (n = 10/24; 95% CI 22.1% to 63.4%) if one or more isolates were resistant (relative risk 1.57, 95% CI 0.96 to 3.06). Based on this study, amikacin combined with ampicillin remains an appropriate antimicrobial drug combination for initial treatment of foals with sepsis.

KW - Amikacin

KW - Ampicillin

KW - Antimicrobial resistance

KW - Equine

KW - Neonatal intensive care unit

UR - http://www.scopus.com/inward/record.url?scp=85057895101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057895101&partnerID=8YFLogxK

U2 - 10.1016/j.tvjl.2018.11.012

DO - 10.1016/j.tvjl.2018.11.012

M3 - Article

VL - 243

SP - 74

EP - 76

JO - Veterinary Journal

JF - Veterinary Journal

SN - 1090-0233

ER -